Primary immunodeficiencyGene: CFHR3
Not enough evidence for monogenic PID
Created: 20 Jun 2022, 10:41 a.m. | Last Modified: 20 Jun 2022, 10:41 a.m.
Panel Version: 2.555
Agree belongs in aHUS panel
Created: 29 Jun 2018, 1:33 p.m.
After internal and external review, it was agreed this gene should remain Amber, the gene is Green on the atypical haemolytic uraemic syndrome panel
Created: 3 Jul 2018, 9:17 a.m.
OriginaI Metadata from IUIS classification table (February, 2018) downloaded 20180614. IUIS Genetic defect (original gene symbol in IUIS download): CFHR1-5 .PanelApp HGNC gene symbol check: CFHR3 . IUIS Disease: Factor H -related protein deficiencies . IUIS Inheritance: AR or AD .T cells: N/A, .B cells: N/A, .IUIS Other affected cells: N/A. IUIS Associated features: Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections. IUIS Major category: Complement Deficiencies. IUIS Subcategory: N/A
Created: 2 Jul 2018, 10:35 a.m.
After internal clinical review it was agreed that the phenotype is better suited to the atypical haemolytic uraemic syndrome panel
Created: 8 Jun 2018, 1:54 p.m.
For internal clinical review- Not sure if s CFHR3 sequence variants that are risk factors for the development of susceptibility to atypical Hemolytic-uremic syndrome is relevant to this panel
Created: 8 Jun 2018, 1:12 p.m.
This gene was absent from the original PanelApp PID panel dataset (review April 2018). However it was listed in external expert immunodeficiency diagnostic gene list(s) GOSH or GRID. In this combined PID panel, this gene has been rated as AMBER and needs further curational review to assess pertinence prior to v1.
Created: 20 Apr 2018, 12:25 p.m.
Original metadata supplied by GRID. GRID Gene Symbol HGNC PanelApp check: CFHR3, GRID_Gene_Symbol: CFHR3, GRID_Transcript_ENS_Community submitted: ENST00000367425, GRID_Transcript_RefSeq: NM_021023.5, GRID_Transcript_ENS_used_on_Production: ENST00000367425
Created: 17 Apr 2018, 12:12 p.m.
Source IUIS Classification December 2019 was added to CFHR3. Added phenotypes Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections for gene: CFHR3 Publications for gene CFHR3 were updated from to 32048120; 32086639
2018-07-12 Louise Daugherty (Genomics England Curator) promoted panel to v1.0. Reviews were assessed, and panel was revised according to expert reviews and further in-house curation based on PanelApp guidelines. Previous panels (A- or hypo-gammaglobulinaemia, Congenital neutropaenia, Agranulocytosis, Combined B and T cell defect, Inherited complement deficiency and SCID panels) that were merged with this panel, were checked again for any changes/new reviews prior to versioning of this panel, these merged panels are now retired/made internal.
Phenotypes for gene CFHR3 were set to Age related macular degeneration, Atypical hemolytic uremic syndrome susceptibility, Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections, Complement Deficiencies
Gene: cfhr3 has been classified as Amber List (Moderate Evidence).
IUIS Classification February 2018 was added to CFHR3. Panel: Primary immunodeficiency disorders
Victorian Clinical Genetics Services was added to CFHR3. Panel: Primary immunodeficiency disorders
Phenotypes for CFHR3 were set to Age related macular degeneration; Atypical hemolytic uremic syndrome susceptibility
Expert Review Amber was added to CFHR3. Panel: Primary immunodeficiency disorders
Phenotypes for gene CFHR3 were set to Age related macular degeneration, Atypical hemolytic uremic syndrome susceptibility, Atypical hemolytic uremic syndrome susceptibility
CFHR3 was added to Primary immunodeficiency disorders panel. Sources: GRID V2.0
CFHR3 was created by Louise Daugherty